Conjugation of bevacizumab to cationic liposomes enhances their tumor-targeting potential

Author： Kuesters Geoffrey M   Campbell Robert B  

Publisher： Future Medicine

ISSN： 1743-5889

Source： Nanomedicine, Vol.5, Iss.2, 2010-02, pp. : 181-192

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumor-targeting nanosystems for the delivery of siRNA

By Aigner Achim  

Nanomedicine, Vol. 2, Iss. 4, 2007-08 ,pp. : 569-572

Future Medicine

Access to resources Recommend Favorite

Bevacizumab for the Treatment of Non-Resectable Pseudomyxoma peritonei Associated with Mucinous Ovarian Tumor of Low Malignant Potential – A Comparison of Two Cases

By  

Case Reports in Oncology, Vol. 3, Iss. 1, 2009-01 ,pp. : 1-8

Karger

Access to resources Recommend Favorite

Expression, purification, refolding, and characterization of octreotide-interleukin-2: A chimeric tumor-targeting protein

By          

International Journal of Molecular Medicine, Vol. 28, Iss. 4, 2011-01 ,pp. : 549-556

Spandidos Publications

Access to resources Recommend Favorite

Tumor-targeting novel manganese complex induces ROS-mediated apoptotic and autophagic cancer cell death

By  

International Journal of Molecular Medicine, Vol. 35, Iss. 3, 2015-01 ,pp. : 607-616

Spandidos Publications

Access to resources Recommend Favorite

Chronic Alcohol Exposure Enhances Lipopolysaccharide‐Induced Lung Injury in Mice: Potential Role of Systemic Tumor Necrosis Factor‐Alpha

By  

ALCOHOLISM (ELECTRONIC), Vol. 39, Iss. 10, 2015-10 ,pp. : 1978-1988

John Wiley & Sons Inc

Access to resources Recommend Favorite